<p>阿卡迪亚医疗保健（NASDAQ:ACHC - 获取免费报告）预计将在 2025 年第一季度的收益结果于 5 月 12 日星期一市场收盘后公布。分析师预计该公司本季度每股收益为 0.42 美元，收入为 7.699 亿美元。</p>
<p>获取 <strong>阿卡迪亚医疗保健</strong> 的提醒：</p>
<h2>阿卡迪亚医疗保健股价上涨 2.3%</h2>
<ul>
<li>Neurogene 股票暴跌 44%：这家生物科技公司还有希望吗？</li>
</ul>
<p>NASDAQ:ACHC 周一开盘价为 23.31 美元。该公司的市值为 21.5 亿美元，市盈率为 7.64，市盈增长比率为 1.46，贝塔系数为 1.01。该公司的债务股本比率为 0.60，流动比率为 1.07，速动比率为 1.07。该公司的 50 日移动平均价格为 27.61 美元，200 日移动平均价格为 37.30 美元。阿卡迪亚医疗保健的年低点为 20.36 美元，年高点为 82.41 美元。</p>
<h2>分析师升级和降级</h2>
<p>多家股票研究分析师对该股票进行了评论。巴克莱将阿卡迪亚医疗保健的股票评级从 “增持” 下调至 “持平”，并在 2 月 28 日的研究报告中将其目标价从 43.00 美元下调至 35.00 美元。StockNews.com 在 1 月 6 日的研究报告中将阿卡迪亚医疗保健的股票评级从 “持有” 下调至 “卖出”。加拿大皇家银行在 3 月 3 日的报告中将阿卡迪亚医疗保健的目标价从 64.00 美元下调至 43.00 美元，并对该股票给予 “跑赢大盘” 的评级。TD Cowen 在 1 月 7 日的研究报告中将阿卡迪亚医疗保健的目标价从 70.00 美元下调至 66.00 美元，并对该公司给予 “买入” 评级。最后，瑞穗在 3 月 25 日的研究报告中将阿卡迪亚医疗保健的目标价从 48.00 美元下调至 37.00 美元，并对该股票给予 “中性” 评级。一位分析师对该股票给予了 “卖出” 评级，三位分析师给予了 “持有” 评级，六位分析师给予了 “买入” 评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 “适度买入”，平均目标价为 50.39 美元。</p>
<p><strong>阅读我们对阿卡迪亚医疗保健的最新分析</strong></p>
<h2>关于阿卡迪亚医疗保健</h2>
<p>（获取免费报告）</p>
<p>阿卡迪亚医疗保健公司在美国和波多黎各提供行为健康服务。该公司开发和运营急性住院精神病设施、包括住宅康复设施和饮食失调设施的专业治疗设施、综合治疗中心和住宅治疗中心，以及为社区的行为健康和康复需求提供的门诊行为健康服务设施。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票比阿卡迪亚医疗保健更好</li>
<li>投资者需要了解即将上市的 IPO</li>
<li>西部数据：存储行业是否准备反弹？</li>
<li>股票拆分，真的会影响投资者吗？</li>
<li>Wingstop 股票因第一季度超预期和扩张前景而上涨</li>
<li>想在下跌趋势中获利？下跌趋势解析。</li>
<li>为什么像埃克森美孚和赫斯这样的能源股票再次受到关注</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUNIQw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUNIQw"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在阿卡迪亚医疗保健吗？</h2>
<p>在你考虑阿卡迪亚医疗保健之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前立即购买……而阿卡迪亚医疗保健并不在名单上。</p>
<p>虽然阿卡迪亚医疗保健目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

阿卡迪亚医疗保健

<p>阿卡迪亚医疗保健 (NASDAQ: ACHC) 将于 5 月 12 日公布 2025 年第一季度财报，预计每股收益为 0.42 美元，收入为 7.699 亿美元。该股开盘价为 23.31 美元，市值为 21.5 亿美元。分析师的评级不一，普遍共识为 “适度买入”，平均目标价为 50.39 美元。最近的评级下调包括巴克莱和 StockNews.com，而 TD Cowen 和加拿大皇家银行则设定了更高的目标价。阿卡迪亚医疗保健在美国和波多黎各提供行为健康服务</p>

<p>Acadia Healthcare (NASDAQ:ACHC - Get Free Report) is projected to announce its Q1 2025 earnings results after the market closes on Monday, May 12th. Analysts expect the company to announce earnings of $0.42 per share and revenue of $769.90 million for the quarter.</p>
<div class="lb-trans"><p>阿卡迪亚医疗保健（NASDAQ:ACHC - 获取免费报告）预计将在 2025 年第一季度的收益结果于 5 月 12 日星期一市场收盘后公布。分析师预计该公司本季度每股收益为 0.42 美元，收入为 7.699 亿美元。</p>
</div><p>Get <strong>Acadia Healthcare</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>阿卡迪亚医疗保健</strong> 的提醒：</p>
</div><h2>Acadia Healthcare Trading Up 2.3 %</h2>
<div class="lb-trans"><h2>阿卡迪亚医疗保健股价上涨 2.3%</h2>
</div><ul>
<li>Neurogene Stock Plummets 44%: Is All Hope Lost for This Biotech?&#34;</li>
</ul>
<div class="lb-trans"><ul>
<li>Neurogene 股票暴跌 44%：这家生物科技公司还有希望吗？</li>
</ul>
</div><p>NASDAQ:ACHC opened at $23.31 on Monday. The firm has a market capitalization of $2.15 billion, a price-to-earnings ratio of 7.64, a price-to-earnings-growth ratio of 1.46 and a beta of 1.01. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. The business has a fifty day moving average price of $27.61 and a 200-day moving average price of $37.30. Acadia Healthcare has a one year low of $20.36 and a one year high of $82.41.</p>
<div class="lb-trans"><p>NASDAQ:ACHC 周一开盘价为 23.31 美元。该公司的市值为 21.5 亿美元，市盈率为 7.64，市盈增长比率为 1.46，贝塔系数为 1.01。该公司的债务股本比率为 0.60，流动比率为 1.07，速动比率为 1.07。该公司的 50 日移动平均价格为 27.61 美元，200 日移动平均价格为 37.30 美元。阿卡迪亚医疗保健的年低点为 20.36 美元，年高点为 82.41 美元。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师升级和降级</h2>
</div><p>A number of equities research analysts have commented on the stock. Barclays cut shares of Acadia Healthcare from an &#34;overweight&#34; rating to an &#34;equal weight&#34; rating and decreased their target price for the stock from $43.00 to $35.00 in a research note on Friday, February 28th. StockNews.com cut shares of Acadia Healthcare from a &#34;hold&#34; rating to a &#34;sell&#34; rating in a research note on Monday, January 6th. Royal Bank of Canada decreased their price target on Acadia Healthcare from $64.00 to $43.00 and set an &#34;outperform&#34; rating on the stock in a report on Monday, March 3rd. TD Cowen dropped their price objective on Acadia Healthcare from $70.00 to $66.00 and set a &#34;buy&#34; rating for the company in a research note on Tuesday, January 7th. Finally, Mizuho decreased their target price on Acadia Healthcare from $48.00 to $37.00 and set a &#34;neutral&#34; rating on the stock in a research note on Tuesday, March 25th. One analyst has rated the stock with a sell rating, three have given a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $50.39.</p>
<div class="lb-trans"><p>多家股票研究分析师对该股票进行了评论。巴克莱将阿卡迪亚医疗保健的股票评级从 “增持” 下调至 “持平”，并在 2 月 28 日的研究报告中将其目标价从 43.00 美元下调至 35.00 美元。StockNews.com 在 1 月 6 日的研究报告中将阿卡迪亚医疗保健的股票评级从 “持有” 下调至 “卖出”。加拿大皇家银行在 3 月 3 日的报告中将阿卡迪亚医疗保健的目标价从 64.00 美元下调至 43.00 美元，并对该股票给予 “跑赢大盘” 的评级。TD Cowen 在 1 月 7 日的研究报告中将阿卡迪亚医疗保健的目标价从 70.00 美元下调至 66.00 美元，并对该公司给予 “买入” 评级。最后，瑞穗在 3 月 25 日的研究报告中将阿卡迪亚医疗保健的目标价从 48.00 美元下调至 37.00 美元，并对该股票给予 “中性” 评级。一位分析师对该股票给予了 “卖出” 评级，三位分析师给予了 “持有” 评级，六位分析师给予了 “买入” 评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 “适度买入”，平均目标价为 50.39 美元。</p>
</div><p><strong>Read Our Latest Analysis on Acadia Healthcare</strong></p>
<div class="lb-trans"><p><strong>阅读我们对阿卡迪亚医疗保健的最新分析</strong></p>
</div><h2>About Acadia Healthcare</h2>
<div class="lb-trans"><h2>关于阿卡迪亚医疗保健</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.</p>
<div class="lb-trans"><p>阿卡迪亚医疗保健公司在美国和波多黎各提供行为健康服务。该公司开发和运营急性住院精神病设施、包括住宅康复设施和饮食失调设施的专业治疗设施、综合治疗中心和住宅治疗中心，以及为社区的行为健康和康复需求提供的门诊行为健康服务设施。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Acadia Healthcare</li>
<li>What Investors Need to Know About Upcoming IPOs</li>
<li>Western Digital: Is the Storage Sector Set for a Rebound?</li>
<li>Stock Splits, Do They Really Impact Investors?</li>
<li>Wingstop Stock Jumps on Q1 Beat, Expansion Outlook</li>
<li>Want to Profit on the Downtrend? Downtrends, Explained.</li>
<li>Why Energy Stocks Like Exxon and Hess Are Back in Focus</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比阿卡迪亚医疗保健更好</li>
<li>投资者需要了解即将上市的 IPO</li>
<li>西部数据：存储行业是否准备反弹？</li>
<li>股票拆分，真的会影响投资者吗？</li>
<li>Wingstop 股票因第一季度超预期和扩张前景而上涨</li>
<li>想在下跌趋势中获利？下跌趋势解析。</li>
<li>为什么像埃克森美孚和赫斯这样的能源股票再次受到关注</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUNIQw" alt="" original-src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=NASDAQ&amp;Symbol=ACHC"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Acadia Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在阿卡迪亚医疗保健吗？</h2>
</div><p>Before you consider Acadia Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑阿卡迪亚医疗保健之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前立即购买……而阿卡迪亚医疗保健并不在名单上。</p>
</div><p>While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然阿卡迪亚医疗保健目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

阿卡迪亚医疗保健（ACHC）预计将在周一公布财报